Genetic and mechanistic basis for rotor syndrome uncovered

The main symptom of Rotor syndrome is jaundice caused by a buildup of a substance known as conjugated bilirubin. Bilirubin is a yellow substance generated in large quantities when the body recycles red blood cells. It is conjugated in the liver to make it soluble in water so that it can be cleared from the body. Although Rotor syndrome is known to be a genetic disorder, it is not known which genes are involved.

However, a team of researchers — led by Alfred Schinkel, at The Netherlands Cancer Institute, The Netherlands; and Milan Jirsa, at the Institute for Clinical and Experimental Medicine, Czech Republic — has now linked genetic mutations predicted to cause complete and simultaneous deficiencies of the proteins OATP1B1 and OATP1B3 to syndrome in 8 families.

Detailed analysis in mice identified the underlying mechanism involved. Moreover, further screening of Rotor syndrome families suggested that although complete lack of either OATP1B1 or OATP1B3 alone does not cause Rotor syndrome, it could cause hypersensitivity to certain drugs.

More information: Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver, Journal of Clinical Investigation.

Provided by Journal of Clinical Investigation

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Genetic analysis reveals range of Rett syndrome

Mar 11, 2008

The first comprehensive analysis of the clinical effects of genetic mutations involved in Rett syndrome will enable affected families to receive a more accurate indication of their child’s prognosis.

Gene discovered for Weaver syndrome

Dec 15, 2011

Scientists have found a gene that causes Weaver syndrome, a rare genetic disorder that typically causes large size at birth, tall stature, developmental delay during childhood, and intellectual disability. Published today ...

Drug treatment for Marfan syndrome looks promising

Jun 26, 2008

A small study in 18 pattients assessing the effectiveness of the drug losartan for treating Marfan syndrome in children has yielded encouraging results. Reporting in the June 26 issue of The New England Journal of Medicine, Johns ...

Recommended for you

The secret of DNA methylation

8 hours ago

Methylation refers to a chemical modification of DNA and this modification can occur in millions of positions in the DNA sequence. Until now, scientists believed that this epigenetic phenomenon actively reduced the expression ...

Aspirin may fight cancer by slowing DNA damage

11 hours ago

Aspirin is known to lower risk for some cancers, and a new study led by a UC San Francisco scientist points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells ...

Study identifies protein essential for normal heart function

Jun 17, 2013

A study by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences and the Department of Pharmacology at the University of California, San Diego, shows that a protein called MCL-1, which promotes cell survival, ...

Scouring the genome of adenoid cystic carcinoma

Jun 17, 2013

Adenoid cystic carcinoma (ACC) is a slow-growing and often fatal malignancy that can occur at multiple organ site, but is most frequently found in the salivary glands. The primary treatment is surgical removal; however, the ...

Gene variants may play role in obesity

Jun 17, 2013

(HealthDay)—Two new studies offer some solace to those who can't control their weight despite diet and exercise by providing more evidence that genetics may play a role in obesity.

Decoding Rett syndrome: New pieces to the puzzle

Jun 17, 2013

(Medical Xpress)—Rett Syndrome is a neurological disorder that affects about 1 in 10,000 girls. Back in 1992, University of Edinburgh researcher Adrian Bird discovered that the protein, MeCP2, plays a major ...

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...